School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Glass House Brands Inc. GLAS

Healthcare · Drug Manufacturers - Specialty & Generic

$4.07last close 2026-10-12 · market cap $384.04M · delayed data

Trailing returns

1M-48.61%
3M-65.50%
6M-49.75%
1Y-50.00%
5Y-15.10%

Basis: Adjusted daily closes.

What it does

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods. The Retail segment owns, and operates retail cannabis stores, and dispensary operation management services.

Open GLAS in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies